Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Virology Journal
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Hypothesis

Torque teno virus: an improved indicator for viral pathogens in drinking waters

Authors: Jennifer S Griffin, Jeanine D Plummer, Sharon C Long

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

Currently applied indicator organism systems, such as coliforms, are not fully protective of public health from enteric viruses in water sources. Waterborne disease outbreaks have occurred in systems that tested negative for coliforms, and positive coliform results do not necessarily correlate with viral risk. It is widely recognized that bacterial indicators do not co-occur exclusively with infectious viruses, nor do they respond in the same manner to environmental or engineered stressors. Thus, a more appropriate indicator of health risks from infectious enteric viruses is needed.

Presentation of the hypothesis

Torque teno virus is a small, non-enveloped DNA virus that likely exhibits similar transport characteristics to pathogenic enteric viruses. Torque teno virus is unique among enteric viral pathogens in that it appears to be ubiquitous in humans, elicits seemingly innocuous infections, and does not exhibit seasonal fluctuations or epidemic spikes. Torque teno virus is transmitted primarily via the fecal-oral route and can be assayed using rapid molecular techniques. We hypothesize that Torque teno virus is a more appropriate indicator of viral pathogens in drinking waters than currently used indicator systems based solely on bacteria.

Testing the hypothesis

To test the hypothesis, a multi-phased research approach is needed. First, a reliable Torque teno virus assay must be developed. A rapid, sensitive, and specific PCR method using established nested primer sets would be most appropriate for routine monitoring of waters. Because PCR detects both infectious and inactivated virus, an in vitro method to assess infectivity also is needed. The density and occurrence of Torque teno virus in feces, wastewater, and source waters must be established to define spatial and temporal stability of this potential indicator. Finally, Torque teno virus behavior through drinking water treatment plants must be determined with co-assessment of traditional indicators and enteric viral pathogens to assess whether correlations exist.

Implications of the hypothesis

If substantiated, Torque teno virus could provide a completely new, reliable, and efficient indicator system for viral pathogen risk. This indicator would have broad application to drinking water utilities, watershed managers, and protection agencies and would provide a better means to assess viral risk and protect public health.
Literature
1.
Snow J: On the mode of communication of cholera. 2nd edition. London: J. Churchill; 1855.
2.
Toranzos GA, McFeters GA: Detection of indicator microorganisms in environmental freshwaters and drinking waters. In Manual of Environmental Microbiology. Edited by: Hurst CJ, Knudsen GR, McInerney MJ, Stetzenbach LD, Walter M. Washington, DC: American Society for Microbiology Press; 1997:184-194.
3.
National Research Council: Indicators for waterborne pathogens. Washington, DC: National Academy Press; 2004.
4.
U.S. Environmental Protection Agency: National Primary Drinking Water Regulations: Total Coliform Rule, Final Rule. Federal Register 1989, 54: 27544-27568.
5.
D'Antonio RG, Winn RE, Taylor JP, Gustafson TL, Current WL, Rhodes MM, Gary GW Jr, Zalac RA: A waterborne outbreak of cryptosporidiosis in normal hosts. Ann Int Med 1985, 103: 886-888.CrossRefPubMed
6.
Craun GF, Berger PS, Calderon RL: Coliform bacteria and waterborne disease outbreaks. JAWWA 1997, 89: 96-104.
7.
Hrudey SE, Hrudey EJ: Safe Drinking Water: Lessons from Recent Outbreaks in Affluent Nations. London: IWA Publishing; 2004.
8.
Bosch A, Lucena F, Diez JM, Gajardo R, Blasi M, Jofre J: Waterborne viruses associated with hepatitis outbreak. JAWWA 1991, 83: 80-83.
9.
Nasser AM, Oman SD: Quantitative assessment of the inactivation of pathogenic and indicator viruses in natural water sources. Water Res 1999, 33: 1748-1752.CrossRef
10.
Gerba CP, Goyal SM, LaBelle RL, Cech I, Bogdan GF: Failure of indicator bacteria to reflect occurrence of enteroviruses in marine waters. Am J Pub Health 1979, 69: 1116-1119.CrossRef
11.
LaBelle RL, Gerba CP, Goyal SM, Melnick JL, Cech I, Bogdan GF: Relationships between environmental factors, bacterial indicators, and the occurrence of enteric viruses in estuarine sediments. Appl Environ Microbiol 1980,39(3):586-596.
12.
Nasser AM, Tchorch Y, Fattal B: Comparative survival of E. coli, F+ bacteriophages, HAV and poliovirus 1 in wastewater and groundwater. Water Sci Technol 1993, 27: 401-407.
13.
Scandura JE, Sobsey MD: Viral and bacterial contamination of groundwater from on-site sewage treatment systems. Water Sci Technol 1997, 35: 141-146.CrossRef
14.
Borchardt M, Haas NL, Hunt RJ: Vulnerability of drinking-water wells in La Crosse, Wisconsin, to enteric-virus contamination from surface water contributions. Appl Environ Microbiol 2004, 70: 5937-5946.PubMedCentralCrossRefPubMed
15.
Jiang SC, Chu W: PCR detection of pathogenic viruses in southern California urban rivers. J Appl Microbiol 2004, 97: 17-28.CrossRefPubMed
16.
Skraber S, Gassilloud B, Gantzer C: Comparison of coliforms and coliphages as tools for assessment of viral contamination in river water. Appl Environ Microbiol 2004, 70: 3644-3649.PubMedCentralCrossRefPubMed
17.
Springthorpe VS, Loh CL, Robertson WJ, Sattar SA: In situ survival of indicator bacteria, MS-2 phage and human pathogenic viruses in river water. Water Sci Technol 1993, 27: 413-420.CrossRef
18.
Bosch A: Human enteric viruses in the water environment: a minireview. Int Microbiol 1998, 1: 191-196.PubMed
19.
Fong TT, Lipp EK: Enteric viruses of humans and animals in aquatic environments: health risks, detection, and potential water quality assessment tools. Microbiol Mol Biol Rev 2005, 69: 357-371.PubMedCentralCrossRefPubMed
20.
Macler BA, Merkle JC: Current knowledge on groundwater microbial pathogens. Hydrol J 2000, 8: 29-40.
21.
Azadpour-Keeley A, Faulkner BR, Chen JS: Movement and longevity of viruses in the subsurface. EPA Ground Water Issue 2003, 1-24.
22.
Reynolds KA, Mena KD, Gerba CP: Risk of waterborne illness via drinking water in the United States. Rev Environ Contam Toxicol 2008, 192: 117-158.PubMed
23.
Bitton G, Farrah SR, Ruskin RH, Butner J, Chou YJ: Survival of pathogenic and indicator organisms in groundwater. Ground Water 1983, 21: 405.CrossRef
24.
Payment P, Armon R: Virus removal by drinking water treatment processes. CRC Crit Rev Environ Contr 1989, 19: 15-31.CrossRef
25.
Keswick BH, Gerba CP, DuPont HL, Rose JB: Detection of enteric viruses in treated drinking water. Appl Environ Microbiol 1984, 47: 1290-1294.PubMedCentralPubMed
26.
Payment P, Trudel M, Plante R: Elimination of viruses and indicator bacteria at each step of treatment during preparation of drinking water at seven water treatment plants. Appl Environ Microbiol 1985, 49: 1418-1428.PubMedCentralPubMed
27.
Jacangelo JG, Laine JM, Carns KE, Cummings EW, Mallevaille J: Low-pressure membrane filtration for removing Giardia and microbial indicators. JAWWA 1991, 83: 97-106.
28.
Jacangelo JG, Adham SS, Laine JM: Mechanism of Cryptosporidium, Giardia, and MS2 virus removal by MF and UF. JAWWA 1995, 87: 107.
29.
Nasser A, Weinberg D, Dinoor N, Fattal B, Adin A: Removal of hepatitis virus (HAV), poliovirus and MS2 coliphage by coagulation and high rate filtration. Water Sci Technol 1995, 31: 63-68.CrossRef
30.
Yoo S, Brown DR, Pardini RJ, Bentson GD: Microfiltration: a case study. JAWWA 1995, 87: 38-49.
31.
Hagen K: Removal of particles, bacteria and parasites with ultrafiltration for drinking water treatment. Desalination 1998, 119: 85-91.CrossRef
32.
Harrington GW, Xagoraraki I, Assavasilavasukul P, Standridge JH: Effect of filtration conditions on removal of emerging waterborne pathogens. JAWWA 2003, 95: 95-104.
33.
34.
Keswick BH, Satterwhite TK, Johnson PC, DuPont HL, Secor SL, Bitsura JA, Gary GW, Hoff JC: Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol 1985, 50: 261-264.PubMedCentralPubMed
35.
Chang JCH, Ossoff SF, Lobe DC, Dorfman MH, Dumais CM, Qualls RG, Johnson JD: UV inactivation of pathogenic and indicator organisms. Appl Environ Microbiol 1985, 49: 1361-1365.PubMedCentralPubMed
36.
37.
Osawa S, Furuse K, Watanabe I: Distribution of ribonucleic acid coliphages in animals. Appl Environ Microbiol 1981, 41: 164-168.PubMedCentralPubMed
38.
Furuse K: Distribution of coliphages in the environment: general considerations. In Phage Ecology. Edited by: Goyal SM, Gerba CP, Bitton G. New York: Wiley-Interscience; 1987:87-123.
39.
Chung H, Sobsey MD: Comparative survival of indicator viruses and enteric viruses in seawater and sediment. Water Sci Technol 1993, 27: 425-428.
40.
San Martin C, Burnett RM, de Haas F, Heinkel R, Rutten T, Fuller SD, Butcher SJ, Bamford DH: Combined EM/X-ray imaging yields a quasi-atomic model of the adenovirus-related bacteriophage PRD1 and shows key capsid and membrane interactions. Structure 2001, 9: 917-930.CrossRef
41.
U.S. Environmental Protection Agency: Method 1601: male-specific (F+) and somatic coliphage in water by two-step enrichment procedure. In EPA 821-R-01-030. Office of Water, Washington, DC; 2001.
42.
U.S. Environmental Protection Agency: Method 1602: Male-specific (F+) and somatic coliphage in water by single agar layer procedure. In EPA 821-R-01-029. Office of Water, Washington, DC; 2001.
43.
Long SC, Sobsey MD: A comparison of the survival of F+RNA and F+DNA coliphages in lake water microcosms. J Water Health 2004, 2: 15-22.PubMed
44.
Pang L, Close M, Goltz M, Sinton L, Davies H, Hall C, Stanton G: Estimation of septic tank setback distances based on transport of E. coli and F-RNA phages. Environ Int 2004, 29: 907-921.CrossRefPubMed
45.
Long SC, Mahar EJ, Pei R, Arango C, Shafer E, Schoenberg TH: Development of source-specific indicator organisms for drinking water. In Technical Report. American Water Works Association Research Foundation, Denver, CO; 2002.
46.
Long SC, El-Khoury SS, Oudejans S, Sobsey MD, Vinje J: Assessment of sources and diversity of male-specific coliphages for source tracking. Environ Eng Sci 2005, 22: 367-377.CrossRef
47.
Kopecka H, Dubrou S, Prevot J, Marechal J, Lopez-Pila JM: Detection of naturally occurring enteroviruses in waters by reverse transcription, polymerase chain reaction, and hybridization. Appl Environ Microbiol 1993, 59: 1213-1219.PubMedCentralPubMed
48.
Metcalf TG, Melnick JL, Estes MK: Environmental virology: from detection of virus in sewage and water by isolation to identification by molecular biology – a trip of over 50 years. Annu Rev Microbiol 1995, 49: 461-487.CrossRefPubMed
49.
Haramoto E, Katayama H, Oguma K, Yamashita H, Tajima A, Nakajima H, Ohgaki S: Seasonal profiles of human noroviruses and indicator bacteria in a wastewater treatment plant in Tokyo, Japan. Water Sci Technol 2006, 54: 301-308.CrossRefPubMed
50.
Straub TM, Bentrup KH, Orosz-Coghlan P, Dohnalkova A, Mayer BK, Bartholomew RA, Valdez CO, Bruckner-Lea CJ, Gerba CP, Abbaszadegan M, Nickerson CA: In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis 2007, 13: 396-403.PubMedCentralCrossRefPubMed
51.
Jiang SC: Adenovirus as an index of human viral contamination. U.S. EPA Workshop on Microbial Source Tracking: 5 February 2002; Irvine 2002, 75-78.
52.
Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M: A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997, 241: 92-97.CrossRefPubMed
53.
Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Iizuka H, Miyakawa Y, Mayumi M: Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998, 10: 1-16.CrossRef
54.
Miyata H, Tsunoda H, Kazi A, Yamada A, Khan MA, Murakami J, Kamahora T, Shiraki K, Hino S: Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol 1999, 73: 3582-3586.PubMedCentralPubMed
55.
Biagini P, Gallian P, Attoui H, Cantaloube JF, de Micco P, de Lamballerie X: Determination and phylogenetic analysis of partial sequences from TT virus isolates. J Gen Virol 1999, 80: 419-424.CrossRefPubMed
56.
Luo K, He H, Liu Z, Liu D, Xiao H, Jiang X, Liang W, Zhang L: Novel variants related to TT virus distributed widely in China. J Med Virol 2002, 67: 118-126.CrossRefPubMed
57.
Nishizawa T, Okamoto H, Tsuda F, Aikawa T, Sugai Y, Konishi K, Akahane Y, Ukita M, Tanaka T, Miyakawa T, Mayumi M: Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virol 1999, 73: 9604-9608.PubMedCentralPubMed
58.
Leary TP, Erker JC, Chalmers ML, Desai SM, Mushahwar IK: Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol 1999, 80: 2115-2120.CrossRefPubMed
59.
Vaidya SR, Chitambar SD, Arankalle VA: Polymerase chain reaction-based prevalence of hepatitis A, hepatitis E and TT viruses in sewage from an endemic area. J Hepatol 2002, 37: 131-136.CrossRefPubMed
60.
Haramoto E, Katayama H, Oguma K, Yamashita H, Nakajima E, Ohgaki S: One-year monthly monitoring of Torque teno virus (TTV) in wastewater treatment plants in Japan. Water Res 2005, 39: 2008-2013.CrossRefPubMed
61.
Diniz-Mendes L, de Paula VS, Luz SLB, Niel C: High prevalence of human Torque teno virus in streams crossing the city of Manaus, Brazilian Amazon. J Appl Microbiol 2008, 105: 51-58.CrossRefPubMed
62.
Springfeld C, Bugert JJ, Schnitzler P, Tobiasch E, Kehm R, Darai G: TT virus as a human pathogen: significance and problems. Virus Genes 2000, 20: 35-45.CrossRefPubMed
63.
Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni L: Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001, 14: 98-113.PubMedCentralCrossRefPubMed
64.
Ross RS, Viazov S, Runde V, Schaefer UW, Roggendorf M: Detection of TT virus DNA in specimens other than blood. J Clin Virol 1999, 13: 181-184.CrossRefPubMed
65.
Okamoto H, Takahashi M, Nishizawa T, Tawara A, Sugai Y, Sai T, Tanaka T, Tsuda F: Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Comm 2000, 270: 657-662.CrossRefPubMed
66.
Okamoto H, Ukita M, Nishizawa T, Kishimoto J, Hoshi Y, Mizuo H, Tanaka T, Miyakawa Y, Mayumi M: Circular double-stranded forms of TT virus DNA in the liver. J Virol 2000, 74: 5161-5167.PubMedCentralCrossRefPubMed
67.
Okamoto H, Nishizawa T, Takahashi M, Asabe S, Tsuda F, Yoshikawa A: Heterogeneous distribution of TT virus of distinct genotypes in multiple tissues from infected humans. Virology 2001, 288: 358-368.CrossRefPubMed
68.
Pollicino T, Raffa G, Squadrito G, Costantino L, Cacciola I, Brancatelli S, Alafaci C, Florio MG, Raimondo G: TT virus has ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. J Viral Hepat 2003, 10: 95-102.CrossRefPubMed
69.
70.
Simmonds P, Prescott LE, Logue C, Davidson F, Thomas AE, Ludlam CA: TT virus – part of the normal human flora? J Infect Dis 1999, 180: 1748-1750.CrossRefPubMed
71.
Takayama S, Miura T, Matsuo S, Taki M, Sugh S: Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese hemophiliacs. Br J Haematol 1999, 104: 626-629.CrossRefPubMed
72.
Verani M, Casini B, Battistini R, Pizzi F, Rovini E, Carducci A: One-year monthly monitoring of Torque teno virus (TTV) in river water in Italy. Water Sci Technol 2006, 54: 191-195.CrossRefPubMed
73.
de Paula VS, Diniz-Mendes L, Villar LM, Luz SL, Silva LA, Jesus MS, da Silva NM, Gaspar AM: Hepatitis A virus in environmental water samples from the Amazon Basin. Water Res 2007, 41: 1169-1176.CrossRefPubMed
74.
Abe K, Inami T, Asano K, Miyoshi C, Masaki N, Hayashi S, Ishikawa K-I, Takebe Y, Win KM, El-Zayadi AR, Han K-H, Zhang DY: TT virus infection is widespread in the general populations from different geographic regions. J Clin Microbiol 1999, 37: 2703-2705.PubMedCentralPubMed
75.
Desai SM, Muerhoff AS, Leary TP, Erker JC, Simons JN, Chalmers ML, Birkenmeyer LG, Pilot-Matias TJ, Mushahwar IK: Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis 1999, 179: 1242-1244.CrossRefPubMed
76.
Yates MV: Classical indicators in the 21st century – far and beyond the coliform. Water Environ Res 2007, 79: 279-286.CrossRefPubMed
77.
Hill VR, Kahler AM, Jothikumar N, Johnson TB, Hahn D, Cromeans TL: Multistate evaluation of an ultrafiltration-based procedure for simultaneous recovery of enteric microbes in 100-liter tap water samples. Appl Environ Microbiol 2007,73(13):4218-4225.PubMedCentralCrossRefPubMed
78.
Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M: Fecal excretion of an nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol 1998, 56: 128-132.CrossRefPubMed
79.
Maggi F, Fornai C, Zaccaro L, Morrica A, Vatteroni ML, Isola P, Marchi S, Ricchiuti A, Pistello M, Bendenelli M: TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol 2001, 64: 190-194.CrossRefPubMed
80.
Mariscal LF, Lopez-Alcorocho JM, Rodriguez-Inigo E, Ortiz-Movilla N, de Lucas S, Bartolome J, Carreno V: TT virus replicates in stimulated by not in nonstimulated peripheral blood mononuclear cells. Virology 2002, 301: 121-129.CrossRefPubMed
81.
Desai M, Pal R, Deshmukh R, Banker D: Replication of TT virus in hepatocyte and leucocyte cell lines. J Med Virol 2005, 77: 136-143.CrossRefPubMed
Metadata
Title
Torque teno virus: an improved indicator for viral pathogens in drinking waters
Authors
Jennifer S Griffin
Jeanine D Plummer
Sharon C Long
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-112

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue

Research

Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters

Short report

A predominance of R5-like HIV genotypes in vaginal secretions is associated with elevated plasma HIV-1 RNA levels and the absence of anti-retroviral therapy

Research

Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes

Research

Central nervous system Toll-like receptor expression in response to Theiler's murine encephalomyelitis virus-induced demyelination disease in resistant and susceptible mouse strains

Methodology

Plaque assay for human coronavirus NL63 using human colon carcinoma cells

Research

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits